Ovarian Stimulation for IVF
About
Ovarian stimulation is the medication phase of an in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) cycle. Rather than encouraging a single ovulation, the specialist aims to mature several follicles so eggs can be collected for laboratory fertilization. The plan is individualized according to ovarian reserve markers, previous response, medical history and the risk of ovarian hyperstimulation syndrome (OHSS). It does not guarantee a particular number of mature eggs or embryos. Through ZagrebMed, you can request a fertility consultation in Zagreb and share previous IVF records before a protocol is selected.
Key facts
- Purpose: develop several follicles for IVF or ICSI
- Approach: individualized hormone medication
- Evaluation: previous response, AMH or antral follicle count
- Monitoring: ultrasound with selected hormone tests
- Next phase: final maturation trigger and egg retrieval
- Safety: ovarian hyperstimulation and thromboembolic risks require attention
Why does IVF require ovarian stimulation?
During a typical natural menstrual cycle, one follicle becomes dominant. IVF commonly uses controlled hormonal stimulation to recruit more than one follicle, allowing the laboratory to work with several collected eggs if the ovarian response permits. The number of follicles and mature eggs varies substantially, and more stimulation is not necessarily better. Clinicians seek a balance between obtaining a useful number of eggs and avoiding excessive response. This page concerns the medication and monitoring phase, not the later egg retrieval, fertilization or embryo transfer.
Who needs an individualized protocol?
Everyone entering a stimulated IVF cycle needs an individual medical plan. A patient with diminished ovarian reserve may respond differently from someone with polycystic ovaries or a previous excessive response. Age, underlying diagnosis and previous treatment contribute to decision-making. The updated ESHRE ovarian stimulation guideline recommends antral follicle count (AFC) or anti-Müllerian hormone (AMH) to predict a high or low ovarian response. Neither marker measures egg quality or guarantees a live birth.
What happens at the planning appointment?
The team reviews medical history, current medications, previous ultrasound and laboratory findings, earlier IVF cycle reports and any complications. The clinician explains the proposed medication, how the ovaries will be monitored and which symptoms require contact. Consent, infection screening and other preparations follow the treating clinic's standards. The care plan may consider the likelihood of OHSS and methods for lowering risk, including a different protocol or the decision to postpone fresh embryo transfer in selected cases.
How are follicles stimulated?
Fertility medications commonly include gonadotropins that support development of ovarian follicles. Different protocols may also suppress an early hormone surge to reduce the chance of premature ovulation. The timing and dosage are selected by the clinician, not set by a general web page. Patients should receive practical instruction about medicine preparation, injections and what to do about a missed dose. Do not substitute supplements, adjust doses or combine prescribed regimens without professional advice.
Monitoring during stimulation
Transvaginal ultrasound is commonly used to measure the number and size of growing follicles and assess the lining of the uterus. This follicle monitoring is scheduled according to the patient's response rather than a universal calendar. The clinic may use selected blood hormone tests in some situations. Monitoring helps decide whether to change medication, when to trigger final oocyte maturation and whether an overly strong response makes the cycle unsafe. Not every follicle visualized on ultrasound contains an egg that can be retrieved and fertilized.
Final oocyte maturation and the next step
When the follicles reach an appropriate stage, the fertility team may prescribe a carefully timed final maturation trigger. The choice of trigger and timing depend on protocol and OHSS risk. Egg retrieval is then planned as a separate procedure, usually with transvaginal ultrasound guidance. It is important not to confuse the trigger with the entire induction or stimulation treatment. When the risk of OHSS is high, clinicians may consider a freeze-all strategy rather than transferring an embryo in the same cycle.
What results and risks should be discussed?
Stimulation can produce an adequate response, a low response or an excessive response, and occasionally a cycle is changed or cancelled. Possible adverse effects include abdominal discomfort, bloating and injection-site reactions. OHSS is a less common but potentially serious complication; marked abdominal swelling, severe pain, shortness of breath, reduced urination, fainting or clinical deterioration require urgent assessment. Fertility medicines should not be taken without supervision. The relationship between the number of eggs and chance of live birth is individual and influenced by egg and sperm quality.
Understanding a low or high ovarian response
Some people develop fewer follicles than expected despite medication, while others develop a large number and require heightened OHSS precautions. A low response does not necessarily mean that increasing the medication dose will produce better eggs or a live birth. A high response should be evaluated for medical risk rather than celebrated without qualification. The team reviews prior stimulation, ultrasound findings, AMH or AFC and the current response before deciding whether to change a protocol. Patients can ask which outcomes are being monitored, what would trigger an adjustment and whether a freeze-all strategy might reduce risk in their circumstances.
IVF planning for patients from abroad
Share prior stimulation protocols, medication doses if known, AMH or AFC findings, ultrasound scans and previous egg-retrieval results before traveling to Zagreb. Medication teaching, serial scans and egg retrieval may need coordination across multiple dates, and timing can change as follicles grow. Ask how monitoring will be coordinated if some checks are performed outside Croatia. ZagrebMed can help organize an inquiry and the initial consultation, but the clinic determines the clinical schedule and eligibility.
Patient guide
Candidate
People starting a stimulated IVF or ICSI cycle after reproductive specialist assessment. The medication protocol is tailored to expected ovarian response, previous IVF history and risk factors including PCOS, low ovarian reserve and OHSS.
Preparation
Provide earlier IVF protocols, ovarian reserve markers including AMH or AFC when available, medications, hormone results and medical history. Follow the fertility clinic's injection, storage, monitoring and consent instructions. Do not adjust hormone doses or stop prescribed medication without advice.
Treatment
A specialist prescribes an individualized ovarian stimulation regimen, commonly involving gonadotropins and medication to control premature ovulation. Ultrasound and sometimes blood tests monitor response. A final maturation trigger is planned when appropriate, followed by separate oocyte retrieval.
Result
The intended result is development of follicles suitable for egg retrieval. The number of eggs recovered, their maturity and subsequent embryo development cannot be guaranteed. The plan may change if response is too low, too high or medically unsafe.
Precautions
Possible adverse effects include bloating, discomfort and medication reactions. OHSS is potentially serious. Follow urgent-care instructions for severe pain, fast abdominal swelling, breathing trouble, low urine output or fainting. High responders may require a modified trigger or freeze-all plan.
Steps
Assess ovarian reserve and plan a safe protocol
The specialist reviews fertility history, previous IVF results, ultrasound findings and, when available, AMH or antral follicle count. The goal is to estimate low or high ovarian response and identify OHSS risks. The team explains the planned medications, monitoring and possible reasons to change the cycle.
Begin injections with clinical instructions
Use the prescribed medicines according to the fertility team's written instructions. Training may cover injection technique, storage and handling missed doses. Keep a record of treatment days and report unexpected symptoms. Do not increase doses or introduce other hormone preparations on your own.
Attend follicle monitoring and adjust treatment
Ultrasound checks assess the number and growth of follicles; selected blood tests may be added. The clinician may adjust medication in response to the findings. This monitoring also helps recognize an excessive response and decide whether the cycle should proceed, be modified or be cancelled for safety.
Trigger final maturation and prepare for retrieval
When clinically appropriate, the team provides precise instructions for final oocyte maturation and plans the egg retrieval appointment. The trigger method may differ according to OHSS risk. The clinic explains practical preparations for retrieval and whether a later frozen embryo transfer may be safer than a fresh transfer.
F.A.Q.
The aim is to develop multiple follicles so several eggs may be retrieved for possible laboratory fertilization.
AMH or AFC can help estimate ovarian response, not the exact mature egg count, egg quality or future pregnancy outcome.
No. Protocol and doses depend on the diagnosis, previous response and safety risks.
The price depends on the prescribed medications, monitoring and the wider IVF treatment plan. Request an individualized offer through ZagrebMed.
The team selects the timing of a maturation trigger and plans egg retrieval, sometimes adjusting the cycle to manage OHSS risk.

Send an inquiry for the treatment
Start your way towards a successful treatment today. Fill out the form with your data, choose the service you need and we will connect you with the top medical experts in Zagreb.